Stockreport

Humacyte to Present Third Quarter Financial Results and Provide Business Update on November 12, 2025

Humacyte, Inc.  (HUMA) 
PDF DURHAM, N.C., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioe [Read more]